| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Adaptive Biotechnologies Corporation (ADPT) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 17 sells. ADPT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.18M | $51.46M | - | |
| Other | 401.3K | $9.47M | -5,000 | |
| CFO | 256.7K | $6.06M | - | |
| Other | 230.7K | $5.44M | -105,762 | |
| Other | 113.5K | $2.68M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 5, 2025 | Lo Francis78 | Chief People Officer | Sell | 20,875 | $6.99 | $145,845.40 | -3.0% | +23.8% | +98.3% | |
| Mar 5, 2025 | Bobulsky Susan | Chief Commercial Officer, Mrd | Sell | 26,023 | $6.98 | $181,640.54 | -7.0% | +23.8% | +98.3% | |
| Feb 20, 2025 | Robins Chad M62 | CEO And Chairman | Sale+OE | 285,187 | $8.45 | $2,410,699.88 | -5.2% | +9.1% | +82.5% | |
| Feb 18, 2025 | Robins Chad M62 | CEO And Chairman | Sale+OE | 470,368 | $8.47 | $3,985,753.94 | -5.7% | +11.2% | +91.9% | |
| Nov 18, 2024 | Piskel Kyle | Chief Financial Officer | Sell | 248 | $4.98 | $1,235.04 | -0.2% | +76.7% | +193.8% | |
| Aug 22, 2024 | Taylor Stacy L82 | SVP And General Counsel | Sell | 26,922 | $4.50 | $121,079.00 | -16.2% | +0.5% | +195.5% | |
| Mar 5, 2024 | Bobulsky Susan | Chief Commercial Officer, Mrd | Sell | 12,991 | $3.44 | $44,628.88 | -2.5% | -12.4% | +112.4% | |
| Mar 5, 2024 | Taylor Stacy L82 | SVP And General Counsel | Sell | 13,381 | $3.43 | $45,962.92 | -3.8% | -12.4% | +112.4% | |
| Mar 5, 2024 | Benzeno Sharon78 | Chief Commercial Ofc Imm Med | Sell | 29,390 | $3.44 | $100,994.14 | -4.2% | -12.4% | +112.4% | |
| Mar 5, 2024 | Peterson Tycho68 | Chief Financial Officer | Sell | 15,456 | $3.44 | $53,168.64 | -2.8% | -12.4% | +112.4% |